Eltrombopag combined with immunosuppressive therapy in pediatric patients with severe aplastic anemia achieved a 54.9% overall response rate at 26 weeks, with a 71.4% response in relapsed/refractory ...

Aplastic anemia is not a type of cancer, but it can increase the risk of developing leukemia. Aplastic anemia occurs when the bone marrow no longer produces blood cells. Anything that damages stem ...

Aplastic anaemia is a life-threatening bone marrow failure syndrome characterised by pancytopenia and markedly reduced marrow cellularity. Management strategies centre on two principal approaches: ...

Please provide your email address to receive an email when new articles are posted on . Prior trials established the role of haploidentical BMT for severe aplastic anemia. Two trials underway have the ...